Table 1.
(A) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Dopamine |
Noradrenalin |
Serotonin |
|||||||
Sham | Core lesion | Shell lesion | Sham | Core lesion | Shell lesion | Sham | Core lesion | Shell lesion | |
Core sample | 4.652 (±0.391) | 1.817 (±0.201) | 4.563 (±0.401) | 0.266 (±0.046) | 0.273 (±0.098) | 0.233 (±0.04) | 0.289 (±0.018) | 0.29 (±0.032) | 0.301 (±0.058) |
Shell sample | 5.147 (±0.488) | 2.088 (±0.476) | 2.034 (0.199) | 0.833 (±0.141) | 0.841 (±0.203) | 0.832 (±0.212) | 0.5 (±0.051) | 0.403 (±0.052) | 0.464 (±0.051) |
CPu sample | 7.873 (±0.371) | 7.271 (±0.438) | 7.87 (±0.258) | 0.165 (±0.009) | 0.147 (±0.008) | 0.151 (±0.006) | 0.242 (±0.016) | 0.218 (±0.01) | 0.244 (±0.015) |
PL sample | 0.58 (±0.003) | 0.25 (±0.003) | 0.35 (±0.005) | 0.21 (±0.01) | 0.163 (±0.013) | 0.143 (±0.011) | 0.17 (±0.009) | 0.159 (±0.012) | 0.168 (±0.008) |
IL sample | 0.122 (±0.057) | 0.045 (±0.007) | 0.056 (±0.019) | 0.379 (±0.099) | 0.237 (±0.042) | 0.196 (±0.038) | 0.221 (±0.022) | 0.185 (±0.026) | 0.222 (±0.19) |
(B) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Dopamine |
Noradrenalin |
Serotonin |
|||||||
Core lesion | Shell lesion | Core lesion | Shell lesion | Core lesion | Shell lesion | ||||
Core sample | −64.7%* (±3.7) | −1.2% (±11.1) | −13.5% (±23.2) | −13.6% (±12.4) | −4.4% (±10.1) | +1.2% (±14.4) | |||
Shell sample | −65.4%* (±7.4) | −69.6%* (±3.2) | −13.6% (±14.7) | −16.4% (±10.5) | −18.5% (±6.4) | −1.4% (±8.1) | |||
CPu sample | +1.7 (±5.1) | +2.9% (±4.3) | −10.7% (±5.8) | +0.3% (±5.6) | −3.8% (±4.9) | +4.5% (±4.6) | |||
PL sample | −51.7%* (±5.7) | −41.2%* (±9.1) | −14.9%* (±5.9) | −30.1%* (±5.1) | −1.6% (±9.1) | +1.6% (±4.7) | |||
IL sample | −34.9%* (±9.1) | −54.9%* (±6.2) | −19.4% (±9.8) | −32.7%* (±7.4) | −9.1% (±10.1) | −8.2% (±6.9) |